![Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan | Journal of the American Heart Association Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/911dbae7-b630-4cea-bfb9-16b914496b92/jah37058-fig-0001.png)
Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan | Journal of the American Heart Association
![Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time - ScienceDirect Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720305131-gr3.jpg)
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time - ScienceDirect
![Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/5584d24a-1666-42dc-9be9-55d76014e9f9/gr1.gif)
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology
![Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review | International Journal of Emergency Medicine | Full Text Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review | International Journal of Emergency Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12245-021-00399-w/MediaObjects/12245_2021_399_Fig1_HTML.png)
Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review | International Journal of Emergency Medicine | Full Text
![Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis | Scientific Reports Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-16355-9/MediaObjects/41598_2017_16355_Fig1_HTML.jpg)
Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis | Scientific Reports
![Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke Dharmasaroja PA, Pattaraarchachai J Neurol India Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke Dharmasaroja PA, Pattaraarchachai J Neurol India](https://www.neurologyindia.com/articles/2011/59/2/images/ni_2011_59_2_180_79132_t2.jpg)
Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke Dharmasaroja PA, Pattaraarchachai J Neurol India
![Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study](https://www.j-stroke.org/upload//thumbnails/jos-2017-01578f1.gif)
Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
![Brigham and Women's (BWH) Pharmacy Department on Twitter: "Thank you to @KayleeMH_Rx and @SamBSnider for a great discussion on acute ischemic stroke management at Wednesday's Contemporary Pharmacotherapy: Collaborative Clinical Explorations series! 🧠💊 Brigham and Women's (BWH) Pharmacy Department on Twitter: "Thank you to @KayleeMH_Rx and @SamBSnider for a great discussion on acute ischemic stroke management at Wednesday's Contemporary Pharmacotherapy: Collaborative Clinical Explorations series! 🧠💊](https://pbs.twimg.com/media/FD_tjXYVkAE3WDd.jpg)
Brigham and Women's (BWH) Pharmacy Department on Twitter: "Thank you to @KayleeMH_Rx and @SamBSnider for a great discussion on acute ischemic stroke management at Wednesday's Contemporary Pharmacotherapy: Collaborative Clinical Explorations series! 🧠💊
![PDF] Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study | Semantic Scholar PDF] Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6020fac9bf94e315863994fcd612213cd55fab60/4-Figure1-1.png)
PDF] Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study | Semantic Scholar
![Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c6c6d696-5c5f-4706-be44-e96f91a6955f/rth212795-gra-0004-m.jpg)
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
![Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment | Stroke: Vascular and Interventional Neurology Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment | Stroke: Vascular and Interventional Neurology](https://www.ahajournals.org/cms/asset/51e033dd-8672-4d0a-9115-3b39fe61d31a/svi212001-gra-0001.png)
Tenecteplase Improves Door‐to‐Needle Time in Real‐World Acute Stroke Treatment | Stroke: Vascular and Interventional Neurology
![Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke - ScienceDirect Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1052305718300776-yjscd3576-fig-0001.jpg)
Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke - ScienceDirect
![Stroke AHA/ASA on Twitter: "Check out the #VisualAbstract summarizing work in which authors showed that a lower dose of 0.6mg/kg alteplase is as effective as standard medical treatment in #stroke with unknown Stroke AHA/ASA on Twitter: "Check out the #VisualAbstract summarizing work in which authors showed that a lower dose of 0.6mg/kg alteplase is as effective as standard medical treatment in #stroke with unknown](https://pbs.twimg.com/media/EVHR37LUcAEF1OL.jpg:large)
Stroke AHA/ASA on Twitter: "Check out the #VisualAbstract summarizing work in which authors showed that a lower dose of 0.6mg/kg alteplase is as effective as standard medical treatment in #stroke with unknown
![PDF] Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. | Semantic Scholar PDF] Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbb09adedff6618050af35a8ddeb702029a0b2d6/5-Table1-1.png)
PDF] Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. | Semantic Scholar
![Frontiers | Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h Frontiers | Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h](https://www.frontiersin.org/files/Articles/763963/fneur-13-763963-HTML-r2/image_m/fneur-13-763963-g001.jpg)
Frontiers | Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
![The ENCHANTED Trial: Is Low-Dose the Right Dose for Intravenous tPA in Acute Ischemic Stroke? - REBEL EM - Emergency Medicine Blog The ENCHANTED Trial: Is Low-Dose the Right Dose for Intravenous tPA in Acute Ischemic Stroke? - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2016/05/The-ENCHANTED-Trial-Results-1024x340.png)
The ENCHANTED Trial: Is Low-Dose the Right Dose for Intravenous tPA in Acute Ischemic Stroke? - REBEL EM - Emergency Medicine Blog
![Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cd579347-f56a-40c3-b4c2-f1d26d8adc7f/rth212795-gra-0001-m.jpg)